Scrivo, R. (2022) “Secukinumab Treatment in Patients with Spondyloarthritis and Concomitant Demyelinating Disease: Rationale of IL-17 Inhibition and Clinical Outcome”, Archives of Clinical and Medical Case Reports, 6(5), pp. 660–668. Available at: https://fortunejournals.org/ojs/index.php/acmcr/article/view/22670 (Accessed: 15 June 2026).